Literature DB >> 20173051

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.

Eleni Tseliou1, Vasiliki Bessa, Georgios Hillas, Vasiliki Delimpoura, Georgia Papadaki, Charis Roussos, Spyros Papiris, Petros Bakakos, Stelios Loukides.   

Abstract

BACKGROUND: Distinct inflammatory cellular phenotypes of severe refractory asthma (SRA) have been reported. Fractional exhaled nitric oxide (FeNO) primarily is related to eosinophilic inflammation. Exhaled breath condensate (EBC) pH has been suggested as a noninvasive tool in the assessment of patients with asthma. We sought to determine whether FeNO and EBC pH could identify the presence and type of the underlying cellular inflammation in patients with SRA.
METHODS: Twenty-nine patients with SRA, 27 patients with moderate asthma, and 17 healthy subjects underwent FeNO measurement, EBC collection for pH measurement, and sputum induction for cell count identification.
RESULTS: FeNO was significantly higher and pH significantly lower in patients with SRA than in the other groups. In SRA, FeNO levels of > 19 parts per billion were associated with a sensitivity of 0.78 and a specificity of 0.73 for sputum eosinophilia, whereas FeNO levels of < 19 parts per billion were associated with a sensitivity of 0.63 and a specificity of 0.9 for sputum neutrophilia irrespective of the presence of eosinophils. The pH failed to predict the cellular profile in SRA, but a cutoff value of < 7.37 could predict sputum eosinophilia in moderate asthma.
CONCLUSIONS: In patients with SRA, different FeNO threshold values can identify those with predominant eosinophilia as well as those with neutrophilia. FeNO levels were reduced in patients with predominant neutrophilia regardless of the concomitant presence of eosinophilia. Although pH could not identify the cellular profile in SRA, it seemed to be a better index for predicting eosinophilia in moderate asthma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173051     DOI: 10.1378/chest.09-1257

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

3.  Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.

Authors:  Annette T Hastie; Wendy C Moore; Huashi Li; Brian M Rector; Victor E Ortega; Rodolfo M Pascual; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2013-05-21       Impact factor: 10.793

4.  Styrene-associated health outcomes at a windblade manufacturing plant.

Authors:  Anna-Binney McCague; Jean M Cox-Ganser; Joshua M Harney; K Udeni Alwis; Benjamin C Blount; Kristin J Cummings; Nicole Edwards; Kathleen Kreiss
Journal:  Am J Ind Med       Date:  2015-08-25       Impact factor: 2.214

5.  Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.

Authors:  Anne M Fitzpatrick; Janet T Holbrook; Christine Y Wei; Meredith S Brown; Robert A Wise; W Gerald Teague
Journal:  J Allergy Clin Immunol Pract       Date:  2014-05-21

6.  Nitric oxide sensors using nanospiral ZnO thin film deposited by GLAD for application to exhaled human breath.

Authors:  Pingxiang Luo; Min Xie; Jingting Luo; Hao Kan; Qiuping Wei
Journal:  RSC Adv       Date:  2020-04-15       Impact factor: 4.036

Review 7.  Biomarkers and severe asthma: a critical appraisal.

Authors:  Alessandra Chiappori; Laura De Ferrari; Chiara Folli; Pierluigi Mauri; Anna Maria Riccio; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2015-10-01

Review 8.  Clinical utility of asthma biomarkers: from bench to bedside.

Authors:  Susanne Jh Vijverberg; Bart Hilvering; Jan Am Raaijmakers; Jan-Willem J Lammers; Anke-Hilse Maitland-van der Zee; Leo Koenderman
Journal:  Biologics       Date:  2013-08-29

9.  The Value of Induced Sputum in the Diagnosis and Management of Children with Bronchial Asthma.

Authors:  Sorana Staticescu; Paraschiva Chereches-Panta; Gabriela Ichim; Madalina Valeanu; Mircea Victor Nanulescu
Journal:  Clujul Med       Date:  2014-08-05

Review 10.  Diagnosis and management of eosinophilic asthma: a US perspective.

Authors:  Hannah H Walford; Taylor A Doherty
Journal:  J Asthma Allergy       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.